Clinical significance of upregulation of mir-196a-5p in gastric cancer and enriched KEGG pathway analysis of target genes

Asian Pacific Journal of Cancer Prevention

Volumn 16, Issue 5, 2015, Pages 1781-1787

  Li, Hai Long ^a,b   Xie, Shou Pin ^c   Yang, Ya Li ^a   Cheng, Ying Xia ^a   Zhang, Ying ^d   Wang, Jing ^a   Wang, Yong ^a   Liu, Da Long ^c   Chen, Zhao Feng ^b   Zhou, Yong Ning ^b   Wu, Hong Yan ^c  

^a GANSU UNIVERSITY OF CHINESE MEDICINE   (China)

^b LANZHOU UNIVERSITY   (China)

^c The First People Hospital of Lanzhou City   (China)

^d First Hospital of Chinese People's Liberation Army   (China)

Author keywords

Gastric cancer; KEGG pathway; Mir 196a 5p; Oncogenic gene

Indexed keywords

MICRORNA; MIRN196 MICRORNA, HUMAN; TUMOR MARKER;

BIOSYNTHESIS; ENERGY METABOLISM; FEMALE; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GENETICS; HUMAN; MALE; MIDDLE AGED; STOMACH TUMOR; TUMOR CELL LINE; UPREGULATION;

BIOMARKERS, TUMOR; CELL LINE, TUMOR; ENERGY METABOLISM; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MICRORNAS; MIDDLE AGED; STOMACH NEOPLASMS; TRANSCRIPTION, GENETIC; UP-REGULATION;

EID: 84928560946     PISSN: 15137368     EISSN: None     Source Type: Journal    
DOI: 10.7314/APJCP.2015.16.5.1781     Document Type: Article

References (29)

1. Bartels CL, Tsongalis GJ (2010). MicroRNAs: novel biomarkers for human cancer. Ann Biol Clin (Paris), 68, 263-72 (in French).
2. Beta M, Venkatesan N, Vasudevan M, et al (2013). Identification and insilico analysis of retinoblastoma serum microRNA profile and gene targets towards prediction of novel serum biomarkers. Bioinform Biol Insights, 7, 21-34.
3. Christensen BC, Avissar-Whiting M, Ouellet LG, et al (2010). Mature microRNA sequence polymorphism in MIR196A2 is associated with risk and prognosis of head and neck cancer. Clin Cancer Res, 16, 3713-20.
4. Cortes-Sempere M, Ibanez de Caceres I (2011). microRNAs as novel epigenetic biomarkers for human cancer. Clin Transl Oncol, 13, 357-62.
5. Du M, Lu D, Wang Q, et al (2014a). Genetic variations in microRNAs and the risk and survival of renal cell cancer. Carcinogenesis, 35, 1629-35.
6. Du W, Ma XL, Zhao C, et al (2014b). Associations of single nucleotide polymorphisms in miR-146a, miR-196a, miR-149 and miR-499 with colorectal cancer susceptibility. Asian Pac J Cancer Prev, 15, 1047-55.
7. Dweep H, Sticht C, Pandey P, et al (2011). miRWalk--database: prediction of possible miRNA binding sites by "walking" the genes of three genomes. J Biomed Inform, 44, 839-47.
8. Fock KM (2014). Review article: the epidemiology and prevention of gastric cancer. Aliment Pharmacol Ther, 40, 250-60.
9. Gocze K, Gombos K, Juhasz K, et al (2013). Unique microRNA expression profiles in cervical cancer. Anticancer Res, 33, 2561-7.
10. Guo B, Li J, Liu L, et al (2013). Dysregulation of miRNAs and their potential as biomarkers for the diagnosis of gastric cancer. Biomed Rep, 1, 907-12.
11. Hao YX, Wang JP, Zhao LF (2013). Associations between three common microRNA polymorphisms and hepatocellular carcinoma risk in Chinese. Asian Pac J Cancer Prev, 14, 6601-4.
12. Katanoda K, Matsuda T, Matsuda A, et al (2013). An updated report of the trends in cancer incidence and mortality in Japan. Jpn J Clin Oncol, 43, 492-507.
13. Koessler T, Roth A, Cacheux W (2014). [Early gastric cancer: epidemiology, diagnostic and management]. Rev Med Suisse, 10, 1118-22.
14. Lee SJ, Seo JW, Chae YS, et al (2014). Genetic polymorphism of miR-196a as a prognostic biomarker for early breast cancer. Anticancer Res, 34, 2943-9.
15. Li Y-m, Shi B, Li X, et al (2004). Study of the characteristics of gastric carcinoma in Wuwei City of Gansu province. Chinese JGeneral Surgery, 13, 667-9.
16. Liu B, Li J, Cairns MJ (2014). Identifying miRNAs, targets and functions. Brief Bioinform, 15, 1-19.
17. Liu SZ, Wang B, Zhang F, et al (2013). Incidence, survival and prevalence of esophageal and gastric cancer in Linzhou city from 2003 to 2009. Asian Pac J Cancer Prev, 14, 6031-4.
18. Liu XH, Lu KH, Wang KM, et al (2012). MicroRNA-196a promotes non-small cell lung cancer cell proliferation and invasion through targeting HOXA5. BMC Cancer, 12, 348.
19. Ma GJ, Gu RM, Zhu M, et al (2013). Plasma post-operative miR-21 expression in the prognosis of gastric cancers. Asian Pac J Cancer Prev, 14, 7551-4.
20. Romero-Cordoba S, Rodriguez-Cuevas S, Rebollar-Vega R, et al (2012). Identification and pathway analysis of microRNAs with no previous involvement in breast cancer. PLoS One, 7, 31904.
21. Saika K, Sobue T (2013). Cancer statistics in the world. Gan To Kagaku Ryoho, 40, 2475-80.
22. Satoh J (2012). Molecular network analysis of human microRNA targetome: from cancers to Alzheimer's disease. BioData Min, 5, 17.
23. Shenouda SK, Alahari SK (2009). MicroRNA function in cancer: oncogene or a tumor suppressor? Cancer Metastasis Rev, 28, 369-78.
24. Slater EP, Strauch K, Rospleszcz S, et al (2014). MicroRNA-196a and -196b as potential biomarkers for the early detection of familial pancreatic cancer. Transl Oncol, 7, 464-71.
25. Sun M, Liu XH, Li JH, et al (2012). MiR-196a is upregulated in gastric cancer and promotes cell proliferation by downregulating p27(kip1). Mol Cancer Ther, 11, 842-52.
26. Tsai MM, Wang CS, Tsai CY, et al (2014). MicroRNA-196a/-196b promote cell metastasis via negative regulation of radixin in human gastric cancer. Cancer Lett, 351, 222-31.
27. Zhan JF, Chen LH, Chen ZX, et al (2011). A functional variant in microRNA-196a2 is associated with susceptibility of colorectal cancer in a Chinese population. Arch Med Res, 42, 144-8.
28. ZHANG Z-y, WU Z-q, WANG H-j (2009). An analysis of gastric cancer detection and epidemicity in high incidental area with gastric cancer, Wuwei city, Gansu province. China Cancer, 10, 14.
29. Zheng G, Xiong Y, Xu W, et al (2014). A two-microRNA signature as a potential biomarker for early gastric cancer. Oncol Lett, 7, 679-84.